Oxidation of cholesterol by amyloid precursor protein and beta-amyloid peptide.
about
Copper excess, zinc deficiency, and cognition loss in Alzheimer's diseaseExpression of ATP binding cassette-transporter ABCG1 prevents cell death by transporting cytotoxic 7beta-hydroxycholesterolOxysterols in the pathogenesis of major chronic diseasesInsulin in the brain: its pathophysiological implications for States related with central insulin resistance, type 2 diabetes and Alzheimer's diseaseOxidized cholesterol as the driving force behind the development of Alzheimer's diseaseIssues raised involving the copper hypotheses in the causation of Alzheimer's diseaseLoading into nanoparticles improves quercetin's efficacy in preventing neuroinflammation induced by oxysterolsMale-specific association between a gamma-secretase polymorphism and premature coronary atherosclerosis.Metals and cholesterol: two sides of the same coin in Alzheimer's disease pathology.Alzheimer disease beta-amyloid activity mimics cholesterol oxidase.The risks of copper toxicity contributing to cognitive decline in the aging population and to Alzheimer's disease.Sterculic acid antagonizes 7-ketocholesterol-mediated inflammation and inhibits choroidal neovascularization.Biological activities of 7-dehydrocholesterol-derived oxysterols: implications for Smith-Lemli-Opitz syndromeHydralazine modifies Aβ fibril formation and prevents modification by lipids in vitro.An internally controlled peripheral biomarker for Alzheimer's disease: Erk1 and Erk2 responses to the inflammatory signal bradykinin.Roles of cholesterol and lipids in the etiopathogenesis of Alzheimer's disease.Atherosclerosis and Alzheimer--diseases with a common cause? Inflammation, oxysterols, vasculatureMicronutrients and Alzheimer's disease.The involvement of lipid rafts in Alzheimer's disease.Membrane-mediated amyloidogenesis and the promotion of oxidative lipid damage by amyloid beta proteinsPromotion of oxidative lipid membrane damage by amyloid beta proteinsEffects of amyloid beta-peptides on the lysis tension of lipid bilayer vesicles containing oxysterols.Links between copper and cholesterol in Alzheimer's disease.Oxysterols, cholesterol homeostasis, and Alzheimer disease.Environmental and dietary risk factors in Alzheimer's disease.Medical bioremediation of age-related diseases.Therapeutics for Alzheimer's disease based on the metal hypothesisSide effects of oxysterols: cytotoxicity, oxidation, inflammation, and phospholipidosis.Oxysterol-induced rearrangement of the liquid-ordered phase: a possible link to Alzheimer's disease?Paradoxical condensation of copper with elevated beta-amyloid in lipid rafts under cellular copper deficiency conditions: implications for Alzheimer diseaseBrain sterol dysregulation in sporadic AD and MCI: relationship to heme oxygenase-1.Membrane-targeted strategies for modulating APP and Abeta-mediated toxicity.Metal Dyshomeostasis and Their Pathological Role in Prion and Prion-Like Diseases: The Basis for a Nutritional Approach.Direct binding of cholesterol to the amyloid precursor protein: An important interaction in lipid-Alzheimer's disease relationships?Oxidative stress and cell membranes in the pathogenesis of Alzheimer's disease.The role of metallobiology and amyloid-β peptides in Alzheimer's disease.Road to Alzheimer's disease: the pathomechanism underlying.The link between altered cholesterol metabolism and Alzheimer's disease.Brain insulin dysregulation: implication for neurological and neuropsychiatric disorders.Plant polyphenols in the treatment of age-associated diseases: revealing the pleiotropic effects of icariin by network analysis.
P2860
Q22252920-6D608D83-9910-4347-8EDD-7F8208242A6EQ24301664-316702C9-28B6-466D-919B-9D0805B93256Q26864594-A222E379-FB75-499C-B68E-45E992ECE68DQ26866392-740D4C82-EE7E-4CCC-BD0D-B6997F6BCE62Q27023315-43130AAD-9154-466E-85C7-645C407945F4Q28248217-396588F3-197C-4AA8-ABFE-30CCDCD40650Q28538558-031C3064-C1E0-4F40-9217-D5A50651C33DQ33382990-F4185D25-5686-47FA-BCE3-CC887DBBD4FAQ33646882-2B10D2C7-2287-4291-8F39-695C3617F573Q33925332-9607AC43-C271-4E4B-A9DD-3728050AC4C9Q34098350-E1A88112-1E51-47F6-B8F4-CF7122520BF5Q34161139-9AF5A0D0-FD6F-46F6-B499-CE1A40691516Q34188044-7DA82410-49C2-4378-ABC7-D4DBD6B95048Q34549266-7FBFC252-0073-4887-A43E-239DEE5D1F38Q35016567-B42DFDD7-2AB2-4A59-9179-7B4437360729Q35016920-73D212B0-EE79-44D0-B272-9C5656582F28Q35127516-F658725F-E2AD-424F-A6D6-415932789516Q36325146-3E6BBAF3-3628-4C2C-BDA1-DA79447E6455Q36447798-0B212E6A-2B95-49B6-A003-75EE24E4342AQ36477398-92A03771-8826-4E65-B688-A4D7CE47D8EBQ36528165-7B87A468-C015-4C3D-A5A0-9878AADF3E96Q36737142-D3B52D0D-7388-4432-BA6A-22FBEDA6D52EQ36847737-72A18E10-E1D4-4A03-B08A-F7C04B028F92Q36851164-02AC17DE-AEBE-4B3E-9160-E0B9E73932E4Q36870079-17F1E330-108C-4D62-8B46-5B725E47FBA1Q37172423-0A0E06C6-F14C-4182-801A-8744BEB8344CQ37215856-9517CCA8-2323-4636-AF73-D235C4D985D7Q37249379-DDAA2640-709B-4942-842B-06798CD6EE7DQ37356534-2E2143DA-DAF4-4325-8F88-A336B006A78EQ37372156-FC87F911-66A3-46A8-92D6-2C2A063BBDDBQ37405213-9F65143A-0190-4382-AA03-8858C1EBDB2EQ37412637-BBC58900-7518-4C3B-AFCF-4127247BCBE2Q37592662-09B94576-0E89-4202-B46F-08E4DEC5EABBQ37715389-6A913DE5-30CF-4846-9CA6-84230BD4C292Q37847817-D9EFF38F-ABA9-4D6E-98B8-02F4F5BAA643Q37961769-C52AB207-237D-46B0-88EA-8E3A29A2B63CQ37972068-242ED856-67B8-4E9B-8E7E-579C8EF8CF3DQ38023563-112D2E06-DFB3-489A-940B-8C7E738D0634Q38075505-DDAFF4EA-517D-40D1-8D4F-D9D3EFFDFB36Q38169127-F69921D1-5F29-4749-BD14-E86FBF225D63
P2860
Oxidation of cholesterol by amyloid precursor protein and beta-amyloid peptide.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Oxidation of cholesterol by amyloid precursor protein and beta-amyloid peptide.
@en
type
label
Oxidation of cholesterol by amyloid precursor protein and beta-amyloid peptide.
@en
prefLabel
Oxidation of cholesterol by amyloid precursor protein and beta-amyloid peptide.
@en
P2860
P356
P1476
Oxidation of cholesterol by amyloid precursor protein and beta-amyloid peptide.
@en
P2093
Daniel L Alkon
Thomas J Nelson
P2860
P304
P356
10.1074/JBC.M409071200
P407
P577
2004-12-08T00:00:00Z